What Are Acceptable Amounts of Pain Medications

There is no universally acceptable dose of opioid medication, and the question cannot be answered by reference to a single number. The acceptable dose for a specific patient is determined by the clinical assessment of that patient’s specific condition, their response to prior treatments, their risk profile for opioid adverse effects and diversion, and the therapeutic goals established in the treating relationship.

This answer frustrates practitioners who want a bright line that protects them from regulatory scrutiny. The regulatory framework does not provide one, and it does not provide one deliberately. The appropriate dose of opioids for a patient with refractory cancer pain is different from the appropriate dose for a patient with acute postoperative pain, which is different from the appropriate dose for a patient with chronic low back pain who has not responded to non-opioid therapies. Clinical judgment, exercised within the applicable standards of care, is the standard the law applies.

The CDC Opioid Prescribing Guidelines

The Centers for Disease Control and Prevention published clinical practice guidelines for opioid prescribing in 2016, revised in 2022, that represent the most widely cited federal framework for assessing opioid prescribing practices. The guidelines are not law; they are clinical recommendations that courts, regulators, and expert witnesses use as evidence of the standard of care. Understanding them is essential for any prescriber of opioids.

The 2022 revised guidelines recommend starting opioids at the lowest effective dose and titrating cautiously, using immediate-release formulations before extended-release or long-acting opioids, evaluating benefits and harms frequently, and using the minimum effective dose for the minimum necessary duration. The guidelines include dosage thresholds expressed in morphine milligram equivalents that represent clinical benchmarks above which the risk-benefit analysis warrants particular attention: dosages above fifty MME per day require careful justification, and dosages above ninety MME per day require specific documentation of the clinical basis for the exception.

The 2022 revision specifically addressed concerns that the 2016 guidelines had been applied too rigidly, in ways that caused harm to patients with legitimate pain needs by restricting access to medically appropriate opioid therapy. The revised guidelines explicitly caution against using MME thresholds as hard prescribing limits and recognize that some patients require higher doses for legitimate therapeutic reasons. This revision provides clinical and legal support for prescribing that exceeds the 2016 thresholds where the clinical rationale is documented.

Morphine Milligram Equivalents as a Tool, Not a Limit

Morphine milligram equivalents, which convert doses of different opioids to a standardized measure for comparison purposes, are used by regulators, PDMPs, and expert witnesses as a tool for assessing prescribing intensity across different medications and doses. They are not legally defined limits on prescribing, and they are not clinical limits in the absence of state regulations that specifically impose MME thresholds.

A prescriber who regularly prescribes at doses exceeding the CDC guideline benchmarks without documenting the clinical rationale for those doses has created a prescribing pattern that the government’s expert will characterize as inconsistent with the standard of care. The same prescriber who documented the clinical complexity of their patient population, the failure of lower-dose therapy, the specialist consultation obtained, and the specific therapeutic goals that justified the higher doses has created a record that the defense expert can use to explain the deviation from guideline benchmarks as a clinically appropriate exception rather than an indifference to safety.

Combination Prescribing and Its Risks

The combination of opioids with benzodiazepines, muscle relaxants, or other central nervous system depressants is a prescribing pattern that the DEA and government medical experts treat as a significant red flag. The combination substantially increases the risk of respiratory depression and overdose death, and its prevalence in pill mill operations, where the combination was used to enhance the medications’ euphoric effects for patients who were using them non-therapeutically, has made it a prominent investigative trigger.

A practitioner who consistently prescribed this combination can defend the practice only through thorough documentation of the clinical rationale for each component of the combination and the specific patient circumstances that justified the combined prescription despite the recognized risks. The absence of that documentation, in a practice where the combination was routinely prescribed, is the absence of the clinical context that distinguishes legitimate medical management from distribution.

DEFENSE TEAM SPOTLIGHT

Todd Spodek

Lead Attorney & Founder

Featured on Netflix's "Inventing Anna," Todd Spodek brings decades of high-stakes criminal defense experience. His aggressive approach has secured dismissals and acquittals in cases others deemed unwinnable.

NY Bar Admitted Multi-State Licensed Federal Courts

Meet the Full Team

Legal Scenario: What Would You Do?

Scenario

You learn that federal investigators want to interview you about a business transaction you were involved in.

Should you agree to speak with them?

Attorney's Answer

Never agree to a federal interview without an attorney present. Under 18 U.S.C. 1001, any false statement to a federal agent is a felony. An experienced defense attorney can advise you on your rights and ensure you do not inadvertently incriminate yourself.

This is general information only. Contact us for advice specific to your situation.

The question of acceptable amounts is ultimately a question the clinical record answers. The answer is not a number. It is a documented clinical judgment, made for a specific patient at a specific time, that a practitioner exercising reasonable professional discretion would recognize as a legitimate exercise of clinical skill. The documentation that supports that judgment is what makes the amount acceptable in a regulatory and legal context.

Specialty-Specific Standards

The standard of care for opioid prescribing varies by specialty. A pain management specialist who prescribes high-dose opioids to patients with complex chronic pain conditions is held to the standard of care applicable to pain management specialists, which may accommodate higher doses in appropriately documented cases. A primary care physician who prescribes the same doses to patients without the complex chronic pain profile that pain management guidelines associate with high-dose therapy is held to the primary care standard, which is more conservative. The applicable standard is determined by the practitioner’s specialty, their clinical training, and the nature of the patient population they serve.